We could not find any results for:
Make sure your spelling is correct or try broadening your search.
Share Name | Share Symbol | Market | Type | Share ISIN | Share Description |
---|---|---|---|---|---|
C4x Discovery Holdings Plc | LSE:C4XD | London | Ordinary Share | GB00BQQ2RV18 | ORD 1P |
Price Change | % Change | Share Price | Bid Price | Offer Price | High Price | Low Price | Open Price | Shares Traded | Last Trade | |
---|---|---|---|---|---|---|---|---|---|---|
0.00 | 0.00% | 12.00 | 10.30 | 10.80 | - | 0.00 | 01:00:00 |
Industry Sector | Turnover | Profit | EPS - Basic | PE Ratio | Market Cap |
---|---|---|---|---|---|
Pharmaceutical Preparations | 1.71M | -11.11M | -0.0441 | -2.72 | 30.27M |
Date | Subject | Author | Discuss |
---|---|---|---|
29/1/2024 18:24 | One decent rns and it's 20p+ within hrs | gah123 | |
29/1/2024 18:23 | Stop willing it on, it's getting boring now | gah123 | |
26/1/2024 07:46 | If we are going to build an initial share price recovery we do need to get above 14-15p where there has been support in the recent past. I do wonder if the lack of liquidity over the past year has only now given opportunity for some to manage their holdings as we have some new buyers after the AZ news - just a thought tbh. dyor etc | takeiteasy | |
25/1/2024 20:41 | Could be peeved off long term holders, last placing was at 25p! Decent value now i took a starter position today and have another tranche limit order set at 11.5p which is net cash value! | rimau1 | |
25/1/2024 20:18 | Could 5 to 10 bag on the right catalyst, risk is very much to the upside. | gah123 | |
25/1/2024 16:25 | agreed- but the ferocity of the constant selling after game changing positive news is odd to say the least and suggests someone wants this lower - I know not why.. | takeiteasy | |
25/1/2024 13:51 | Someone determined to get badly burnt. Could easily be takenover 5-10 times current price, that's how cheap it is. | gah123 | |
25/1/2024 13:37 | Rare opportunity here | profit7 | |
25/1/2024 12:00 | More chance of 30p than 10p from here, rare gem | gah123 | |
25/1/2024 11:47 | well done - I may not get sub 10p to add now it seems. | takeiteasy | |
25/1/2024 11:26 | I sold my share deal ones and bought them back later. In order to manipulate the market makers into thinking I am out. The trick worked and look at them now. My spread bet ones are going to be super rich. | luckyabbeygale | |
24/1/2024 14:34 | Well the 1.5p has put my spreadbet into a £1,000 loss. As my average price is 14p. However it wouldnt matter if they took another 4p off the price. As my spreadbet account is made up of so many shares. That it would take a massive dow crash to wipe me out. | luckyabbeygale | |
24/1/2024 14:20 | what is wrong with a cash purchase - if MMs know folks are on spread bets they will move the bid below their stop loss and bounce them out - if this is happening then no wonder this share price is turning into a plummeting stone :) | takeiteasy | |
24/1/2024 13:23 | Lots of buying today and a great time to spreadbet this one. | luckyabbeygale | |
24/1/2024 10:13 | More like traders need to hold longer than 2 minutes, little wonder why so many lose money on AIM. | gah123 | |
23/1/2024 12:40 | perhaps we simply need a fresh set of long term investors from the US who have a good grasp of Biotech valuations and can provide more liquidity, this may work via a US listing. Seems to have done the trick for my other biotech holding which also has our large holder here as a major investor so he would understand the process perhaps. Perhaps something that can be raised at the next AGM? | takeiteasy | |
23/1/2024 09:44 | Back to 8p it seems - no support at all at the moment here | takeiteasy | |
22/1/2024 21:07 | ETX usually the poor relation!! To C4XD .... | bloomberg2 | |
22/1/2024 20:39 | Bigger query is whether any of the larger holders are adding as they seem quiet ? | takeiteasy | |
22/1/2024 20:38 | 2.38m sell | takeiteasy | |
22/1/2024 12:54 | What trade? | nigelpm | |
22/1/2024 12:12 | hopefully that is the seller cleared out with that large trade just now...let's watch and see... | takeiteasy | |
20/1/2024 08:49 | An evolutionary year Hunjan said that C4XD is always in discussions with potential partners as they progress their programmes along the development pathway, and partnership is something that could eventually happen with its ongoing work on IBD and other inflammatory diseases. The company is also planning to publish results from its analysis, using PatientSeek, of two phase three clinical trials for Parkinson’s with the Garvan Institute of Medical Research. The sheer broad range of the work being considered is what makes this such a fascinating business to link up with if you have an interest in the world of auto-immunity dyor and no advice intended | takeiteasy |
It looks like you are not logged in. Click the button below to log in and keep track of your recent history.
Support: +44 (0) 203 8794 460 | support@advfn.com
By accessing the services available at ADVFN you are agreeing to be bound by ADVFN's Terms & Conditions